September 25, 2017 1:15 AM ET

Biotechnology

Company Overview of Affibody Medical AB (publ)

Key Executives for Affibody Medical AB (publ)

NameBoard RelationshipsTitleAge
David Bejker M.Sc.4 RelationshipsChief Executive Officer and President42
Karin Nord Ph.D.No RelationshipsCo-Founder and Senior Vice President of Operations48
Stefan Ståhl 20 RelationshipsCo-Founder, Chief Business Officer and Member of Technical Advisory Board--
Mathias Uhlén Ph.D.61 RelationshipsCo-Founder, Deputy Chairman and Member of Scientific Advisory Board63
Hans Wigzell M.D., Ph.D.122 RelationshipsCo-Founder and Member of Scientific Advisory Board79
View More Key Executives

Affibody Medical AB (publ) Board Members*

NameBoard RelationshipsPrimary CompanyAge
Håkan Åström Med. Dr. h.c. 28 RelationshipsTravenol70
Mathias Uhlén Ph.D. 61 RelationshipsAtlas Antibodies AB63
Stefan Ståhl 20 RelationshipsAffibody Medical AB (publ)--
Hans Wigzell M.D., Ph.D. 122 RelationshipsFinnish Society of Sciences and Letters79
Per-Ake Nygren Ph.D. 12 RelationshipsAffibody Medical AB (publ)--
View All Board Members

Affibody Medical AB (publ) Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Nominating Committee Med. Dr. h.c.Håkan Åström28 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$145.8K
145.8K
391.7K
Bonus$24.9K
24.9K
238.0K
Total Short Term Compensation$170.7K
170.7K
486.9K
Total Value of Options
18.4M
Compensation as of Fiscal Year
Affibody Medical AB (publ) CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Kannalife Sciences, Inc. Announces Nick Lowery as New Spokesperson
September 23, 2017 1:50 AM ET
Eleven Biotherapeutics, Inc. Announces Resignation of Arthur Decillis as Chief Medical Officer, Effective as of October 3, 2017
September 22, 2017 8:55 PM ET
Neuralstem, Inc. Announces Board Appointments
September 22, 2017 8:30 PM ET
NantKwest, Inc. Announces Directorate Changes
September 22, 2017 8:06 PM ET
Histogenics Corporation Announces Resignation of Gloria Matthews from Chief Medical Officer, Effective from September 29, 2017
September 22, 2017 1:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Affibody Medical AB (publ), please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.